Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2023-12-28 Governance Information
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
科美诊断技术股份有限公司对外担保管理制度（2023年12月）
Governance Information Classification · 95% confidence The document is titled '科美诊断技术股份有限公司对外担保管理制度' which translates to 'Kemei Diagnostic Technology Co., Ltd. External Guarantee Management System'. It is a detailed internal policy document outlining the company's rules, procedures, and responsibilities regarding external guarantees (担保). It references relevant laws and regulations, internal governance procedures, and disclosure requirements. There is no indication that this is a financial report, audit, earnings release, or any form of shareholder meeting material. It is not a regulatory filing or announcement but rather an internal governance or management policy document. Given the content focuses on governance practices related to external guarantees, it fits best under Governance Information (CGR). The document length is 4154 characters, which is relatively short but contains substantive policy content rather than a mere announcement or certification. Therefore, the classification is CGR with high confidence.
2023-12-28 Chinese
科美诊断技术股份有限公司对外投资管理办法（2023年12月）
Governance Information Classification · 95% confidence The document is titled '科美诊断技术股份有限公司对外投资管理办法' which translates to 'Kemei Diagnostic Technology Co., Ltd. External Investment Management Measures'. It is a detailed internal management policy document outlining the principles, approval authorities, organizational structure, decision-making processes, personnel management, and financial management related to the company's external investments. There is no indication that this is a financial report, earnings release, regulatory filing, or announcement. It is not a report of financial results or an announcement of a report publication. It is a corporate governance or management internal policy document related to investment management. Therefore, the most appropriate classification is 'Governance Information (CGR)', which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 4341 characters, which is consistent with a detailed policy document rather than a brief announcement or a full annual/interim report. Confidence is high due to the clear nature of the document as an internal governance policy.
2023-12-28 Chinese
科美诊断技术股份有限公司防范控股股东及其他关联方资金占用制度（2023年12月）
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled '防范控股股东及其他关联方资金占用制度' (Prevention of Controlling Shareholders and Related Parties' Misappropriation of Company Funds System) issued by 科美诊断技术股份有限公司. It outlines principles, responsibilities, and procedures to prevent misuse of company funds by controlling shareholders and related parties. The content is regulatory and governance-related, focusing on internal controls, board responsibilities, and legal compliance. It does not contain financial statements, earnings data, or audit results. It is not an announcement or a brief summary but a formal governance policy document. Therefore, it best fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-12-28 Chinese
科美诊断技术股份有限公司关联交易管理办法（2023年12月）
Governance Information Classification · 100% confidence The document is titled '科美诊断技术股份有限公司关联交易管理办法' which translates to 'Kemei Diagnostic Technology Co., Ltd. Related Party Transaction Management Measures'. It is a detailed internal policy document outlining the principles, scope, disclosure, decision-making procedures, pricing, and exemptions related to related party transactions. It references relevant laws and regulations such as the Company Law, Securities Law, and Shanghai Stock Exchange rules. The document is a governance and compliance manual rather than a financial report, announcement, or regulatory filing. It does not contain financial statements, earnings data, voting results, or management changes. It is a governance-related document detailing internal rules and procedures for managing related party transactions. Therefore, the most appropriate classification is Governance Information (CGR). The document length (9996 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2023-12-28 Chinese
科美诊断技术股份有限公司独立董事工作规则（2023年12月）
Governance Information Classification · 95% confidence The document is titled '独立董事工作规则' which translates to 'Independent Director Work Rules' for a company. It details the rules, qualifications, duties, and procedures related to independent directors, including legal references and governance practices. There is no financial data, earnings information, or report publication announcement. The content is focused on governance structure and internal rules regarding independent directors. This matches the description of Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2023-12-28 Chinese
科美诊断技术股份有限公司关于修订《公司章程》、修订及制定公司部分治理制度的公告
Governance Information Classification · 95% confidence The document is a detailed announcement from the board of directors of 科美诊断技术股份有限公司 regarding the revision of the company's Articles of Association and various governance-related rules and systems. It includes specific amendments to the company's charter, governance rules, and newly formulated governance policies such as the accounting firm selection system and independent directors' meeting system. The document references regulatory requirements and rules from the Shanghai Stock Exchange and Chinese securities laws. It is not a financial report, earnings release, or audit report, but rather a governance-related announcement about changes to company bylaws and governance practices. The document is not a proxy solicitation or voting results announcement, but a formal disclosure of governance changes requiring shareholder approval. Therefore, the most appropriate classification is Governance Information (CGR). The document length (7477 characters) and content support this classification with high confidence.
2023-12-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.